8-K: Abacus Global Management Reports Record Q2 2025 Growth
Quarterly Results
Abacus Global Management announced record second quarter 2025 results, nearly doubling total revenue and adjusted earnings year-over-year, and raising its full year outlook.
Summary
- Total revenue for the second quarter of 2025 grew 93% year-over-year to $56.2 million, up from $29.1 million in the prior-year period.
- Longevity Funds attracted $123.1 million in capital inflows during Q2 2025.
- GAAP net income attributable to shareholders for Q2 2025 was $17.6 million, a significant increase from $0.7 million in the prior-year period.
- Adjusted net income (non-GAAP) for Q2 2025 grew 87% year-over-year to $21.9 million, compared to $11.7 million in the prior-year period.
- Adjusted EBITDA (non-GAAP) for Q2 2025 increased 89% to $31.5 million, up from $16.7 million in the prior-year period.
- The company raised its full year 2025 outlook for Adjusted net income to between $74 million and $80 million, an increase from the prior outlook of $70 million to $78 million.
- A $20 million Share Repurchase program was authorized by the Board, effective June 5, 2025.
- The company completed an exchange offer and consent solicitation for its outstanding warrants on July 30, 2025, resulting in no warrants remaining outstanding and their delisting from Nasdaq by August 14, 2025.
- Common stock outstanding increased by approximately 5% to 102,555,154 shares following the warrant exchange.
Sentiment
Score: 9
Explanation: The filing indicates very strong financial performance with significant year-over-year growth in key metrics like revenue, net income, and EBITDA. The company raised its full-year outlook, authorized a share repurchase program, and successfully eliminated the warrant overhang, all of which are highly positive signals for investors.
Positives
- Total revenue nearly doubled year-over-year, growing 93% to $56.2 million in Q2 2025.
- GAAP net income increased significantly by $16.9 million to $17.6 million in Q2 2025.
- Adjusted net income grew 87% year-over-year to $21.9 million.
- Adjusted EBITDA grew 89% year-over-year to $31.5 million.
- Full year 2025 Adjusted net income outlook was raised to a range of $74 million to $80 million, implying 59% to 72% growth over 2024.
- Longevity Funds attracted substantial capital inflows of $123.1 million.
- Origination capital deployment increased to $121.8 million in Q2 2025 from $104.7 million in the prior-year period.
- The number of policies held increased to 600 as of Q2 2025, up from 458 in the prior-year period.
- A $20 million Share Repurchase program was authorized, signaling confidence in the company's valuation.
- The overhang of warrants was eliminated through a successful exchange offer, simplifying the capital structure and removing potential dilution uncertainty.
Negatives
- Adjusted EBITDA margin slightly decreased to 56.1% in Q2 2025 from 57.5% in the prior-year period.
- Cash and cash equivalents decreased to $74.8 million as of June 30, 2025, from $131.9 million at December 31, 2024.
- Operating expenses increased, partially offsetting higher revenues.
Risks
- Loss reserves are based on estimates and may be inadequate to cover actual losses.
- Failure to properly price insurance policies could negatively impact financial results.
- The business has geographic concentration, which could expose it to regional economic or regulatory risks.
- The industry is cyclical, which may lead to fluctuations in performance.
- Impact of regulation on the business could be adverse.
- Effects of competition could hinder growth and profitability.
- Failure of relationships with independent agencies could disrupt business operations.
- Inability to meet investment objectives could impact returns.
- Inability to raise capital on favorable terms or at all could limit strategic initiatives.
- The effects of acts of terrorism could impact the business.
- The effectiveness of the control environment, including the identification of control deficiencies, is crucial for operational integrity.
Future Outlook
The company is raising its full year 2025 outlook for Adjusted net income to a range of $74 million to $80 million, reflecting strong second quarter performance. This new range implies significant growth of 59% to 72% compared to the full year 2024 Adjusted net income of $46.5 million. The company aims to establish itself as the leading alternative asset and wealth management company.
Management Comments
- "We delivered another excellent quarter of record profitable growth in the second quarter of 2025, nearly doubling total revenue and adjusted earnings year-over-year, enabling us to raise our full year outlook for adjusted earnings."
- "Our strong performance was driven by robust demand for policyholder liquidity, as well as increased inflows for our new asset management offerings."
- "Our differentiated origination-focused business model, serving both liquidity-seeking consumers and yield-seeking investors, enables us to capture true market value in any macro environment."
- "With our greater scale and capabilities, our ability to consistently execute on our strategic growth initiatives and our expanding brand recognition, we remain steadfast in our mission to establish Abacus as the leading alternative asset and wealth management company."
Industry Context
Abacus Global Management operates in the alternative asset management space, specializing in longevity-based assets. The strong demand for policyholder liquidity and increased inflows into new asset management offerings suggest a robust market for these specialized financial products. The company's focus on a differentiated origination-focused business model positions it to capitalize on market value in various macro environments, aligning with broader trends of investors seeking alternative yield opportunities and consumers seeking liquidity solutions.
Comparison to Industry Standards
- The filing positions Abacus as a 'leader in the alternative asset management space' and highlights its 'differentiated origination-focused business model.'
- While the company reports strong growth metrics like 93% revenue growth and 87% adjusted net income growth, the filing does not provide specific comparable companies, projects, or global benchmarks to assess these results against industry standards.
- The company's stated mission to become the 'leading alternative asset and wealth management company' indicates an ambition to outperform industry peers, but specific comparative data is not presented.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Repurchase Program Authorization | The Board approved a new $20 million Share Repurchase program. | 2025-06-05 | Signals management's confidence in the company's valuation and can enhance shareholder value by reducing share count. |
Related Party Transactions
- Accounts receivable, related party: $10,989,251 as of June 30, 2025.
- Management and performance fee receivable, related party: $14,501,482 as of June 30, 2025.
- Long-term debt, related party: $13,296,214 as of June 30, 2025.
Stakeholder Impact
- Shareholders: Positively impacted by strong financial performance, raised outlook, share repurchase program, and the elimination of warrant overhang, although common stock outstanding increased by approximately 5% due to the warrant exchange.
- Investors (yield-seeking): Benefited from robust demand for policyholder liquidity and increased inflows for new asset management offerings.
- Customers (liquidity-seeking consumers): Served by the company's differentiated origination-focused business model providing policyholder liquidity.
Next Steps
- A webcast and conference call to discuss the company's results was held on August 7, 2025, at 5:00 p.m. Eastern Time.
- Public warrants are expected to be suspended from trading on Nasdaq as of the close of business on August 14, 2025, and subsequently delisted.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Balance sheet comparison date for prior year-end financial figures. |
| 2025-06-05 | Effective date of the newly authorized $20 million Share Repurchase program approved by the Board. |
| 2025-06-12 | Date Abacus hosted its Investor Day and Longevity Summit at Nasdaq in New York City, where a new corporate-focused commercial campaign was announced. |
| 2025-06-30 | End of the second quarterly period for which results are reported. |
| 2025-07-30 | Completion date of the previously announced exchange offer and consent solicitation relating to outstanding warrants. |
| 2025-08-07 | Date of the press release announcing financial results for the quarter ended June 30, 2025, and the earliest event reported on the Form 8-K. |
| 2025-08-07 | Date of the webcast and conference call to discuss the company's results, held at 5:00 p.m. Eastern Time. |
| 2025-08-08 | Date the Form 8-K report was signed. |
| 2025-08-14 | Expected date for public warrants to be suspended from trading on Nasdaq as of the close of business, prior to delisting. |
Recommendation
strong buyThe filing demonstrates exceptional financial performance with nearly doubled revenue and adjusted earnings year-over-year, coupled with a raised full-year outlook. The authorization of a $20 million share repurchase program indicates management's belief in the company's undervaluation, and the successful elimination of the warrant overhang removes a significant capital structure uncertainty. These factors, combined with strong capital inflows into longevity funds and increased policy deployment, suggest robust operational momentum and a positive trajectory for shareholder value.
Keywords
Alternative Asset Management, Longevity Funds, Financial Results, Earnings Report, SEC Filing, Abacus Global Management, ABL, NASDAQ, Share Repurchase, Warrant Exchange, Q2 2025, Financial Services, Life Settlements, Wealth Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.